[Resolution of Ménétrier's disease after eradication of Helicobacter pylori infection]

S Santolaria Piedrafita1, R Conde García, M Abascal Agorreta

  • 1Sección de Aparato Digestivo, Hospital San Jorge, Huesca, Spain. ssantolaria@able.es

Gastroenterologia Y Hepatologia
|June 23, 2004
PubMed

Insights

Ménétrier's disease, a gastric disorder, may improve with Helicobacter pylori eradication. Treating H. pylori infection in patients with Ménétrier's disease can lead to symptom resolution and improved albumin levels.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pathology

Background:

  • Ménétrier's disease is a rare condition causing enlarged gastric folds due to foveolar hyperplasia.
  • It often presents with protein-losing gastroenteropathy and hypoalbuminemia.
  • The exact cause is unknown, but Helicobacter pylori infection is increasingly implicated.

Observation:

  • A case study of a 38-year-old male with protein-losing gastroenteropathy due to Ménétrier's disease.
  • The patient's symptoms and hypoalbuminemia resolved after successful H. pylori eradication therapy.
  • This suggests a potential link between H. pylori and the disease's clinical presentation.

Findings:

  • H. pylori infection was investigated in patients diagnosed with Ménétrier's disease.
  • Eradication of H. pylori was associated with clinical improvement and normalization of albumin levels.
  • This supports H. pylori as a significant factor in some Ménétrier's disease cases.

Implications:

  • H. pylori eradication should be considered a first-line treatment for Ménétrier's disease when infection is present.
  • Further research is warranted to understand the pathogen's role in the disease's etiology.
  • This approach may improve patient outcomes and reduce complications associated with hypoalbuminemia.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...